85 related articles for article (PubMed ID: 1033056)
1. [Glisoxepide treatment in maturity-onset diabetics (author's transl)].
Happ J; Beyer J; Ulreich F; Schöffling K; Krause U; Frönlich A
Dtsch Med Wochenschr; 1976 Nov; 101(45):1643-6. PubMed ID: 1033056
[TBL] [Abstract][Full Text] [Related]
2. Circadian variations of carbohydrate tolerance in maturity onset diabetics treated with sulfonylureas.
Göschke H; Denes A; Girard J; Collard F; Berger W
Horm Metab Res; 1974 Sep; 6(5):386-91. PubMed ID: 4417576
[No Abstract] [Full Text] [Related]
3. [Blood sugar, serum insulin, nonesterified fatty acids and somatotropin in daily profile in adult diabetics under monotherapy with various sulfonylureas].
Happ J; Beyer J; Nest E; Fröhlich A; Althoff PH; Schöffling K
Arzneimittelforschung; 1974 Aug; 24(8):1228-34. PubMed ID: 4214173
[No Abstract] [Full Text] [Related]
4. Comparative effects of two doses of glibenclamide upon metabolic rhythms in maturity-onset diabetics.
Nattrass M; Hinks L; Smythe P; Todd PG; Alberti KG
Diabete Metab; 1978 Sep; 4(3):175-80. PubMed ID: 101402
[TBL] [Abstract][Full Text] [Related]
5. Diurnal pattern of plasma insulin and blood glucose during glibenclamide and glipizide therapy in elderly diabetics.
Groop L; Harno K
Acta Endocrinol Suppl (Copenh); 1980; 239():44-52. PubMed ID: 6776763
[TBL] [Abstract][Full Text] [Related]
6. [Metabolic control in 107 maturity onset diabetic out patients (author's transl)].
Charitanski D; Blouquit Y; Papoz L; Soria J; Rosa J; Tchobroutsky G
Nouv Presse Med; 1980 Feb; 9(9):585-9. PubMed ID: 6987621
[TBL] [Abstract][Full Text] [Related]
7. [Mechanism of action of gliquidone (author's transl)].
Zilker T; Ermler R; Henderkott U; Bottermann P
Dtsch Med Wochenschr; 1975 Aug; 100(35):1733-4, 1739-41. PubMed ID: 808405
[TBL] [Abstract][Full Text] [Related]
8. [Duration of effective hypoglycaemic action of glipizide given once daily (author's transl)].
Azzopardi J; Campbell IW; Clarke BF; Duncan LJ
Med Klin; 1975 Jul; 70(28-29):1214-8. PubMed ID: 809650
[TBL] [Abstract][Full Text] [Related]
9. [Insulin, glucose and free fatty acids in the serum of healthy and diabetic subjects following solitary oral dose of the sulfonylurea derivative glibornuride].
Herrlinger H; Dörfler H; Wolfram G; Zöllner N
Verh Dtsch Ges Inn Med; 1971; 77():550-2. PubMed ID: 5155895
[No Abstract] [Full Text] [Related]
10. Plasma glucagon and clinical control of maturity-onset type diabetes. Effects of diet, placebo and glipizide.
Lecomte MJ; Luyckx AS; Lefebvre PJ
Diabete Metab; 1977 Dec; 3(4):239-43. PubMed ID: 340296
[No Abstract] [Full Text] [Related]
11. Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide.
D'Onofrio F; Pempinello R; Romis L
Arzneimittelforschung; 1972 Nov; 22(11):1879-81. PubMed ID: 4679059
[No Abstract] [Full Text] [Related]
12. [Changes in insulin (IRI) and NEFA levels in diabetic subjects after acute intravenous glipizide and tolbutamide administration].
Fedeli S; Maglia A
Arch Sci Med (Torino); 1977; 134(1):33-8. PubMed ID: 860916
[TBL] [Abstract][Full Text] [Related]
13. Metabolic effects of combined sulphonylurea and metformin therapy in maturity-onset diabetice.
Nattrass M; Hinks L; Smythe P; Todd PG; Alberti KG
Horm Metab Res; 1979 May; 11(5):332-7. PubMed ID: 573232
[TBL] [Abstract][Full Text] [Related]
14. A randomised four-intervention crossover study investigating the effect of carbohydrates on daytime profiles of insulin, glucose, non-esterified fatty acids and triacylglycerols in middle-aged men.
Brynes AE; Mark Edwards C; Ghatei MA; Dornhorst A; Morgan LM; Bloom SR; Frost GS
Br J Nutr; 2003 Feb; 89(2):207-18. PubMed ID: 12575905
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of glibenclamide, gliquidone, glisoxepide and placebo in maturity onset diabetics of differing degrees of severity (author's transl)].
Irsigler K; Ogris E; Steinhardt T; Brändle J; Regal H; Zdolsek I
Wien Klin Wochenschr; 1979 Aug; 91(16):541-50. PubMed ID: 115159
[TBL] [Abstract][Full Text] [Related]
16. [Radioimmunological determination of insulin in patients with manifest diabetes mellitus as a guide for the planning of therapy (author's transl)].
Zilker T; Kränzlin T; Schweigart U; Ermler R; Bottermann P
Med Klin; 1976 Apr; 71(18):761-7. PubMed ID: 818495
[TBL] [Abstract][Full Text] [Related]
17. [Clinical implication of serum insulin determination. Diagnosis and prognosis in patients with apparent secondary failure of treatment with sulfonylureas (author's transl)].
Sachse G; Willms B
Med Klin; 1979 Nov; 74(44):1635-40. PubMed ID: 522809
[TBL] [Abstract][Full Text] [Related]
18. [Behavior of serum insulin under the influence of glisoxepide with and without butylbiguanide].
Birk W; Petrides P
Arzneimittelforschung; 1974 Mar; 24(0):425-9. PubMed ID: 4408033
[No Abstract] [Full Text] [Related]
19. [Palatinite in type II diabetics. Effect on blood-glucose, serum-insulin, C-peptide and free fatty acids].
Petzoldt R; Lauer P; Spengler M; Schöffling K
Dtsch Med Wochenschr; 1982 Dec; 107(50):1910-3. PubMed ID: 6754331
[TBL] [Abstract][Full Text] [Related]
20. [Further results of a multi-centre clinical trial with the oral antidiabetic drug glisoxepide (author's transl)].
Blumenbach L; Kiesselbach N; Lehnert J
Arzneimittelforschung; 1976; 26(5):931-43. PubMed ID: 786303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
